Paradigm Biopharmaceuticals Ltd has released a press release.
Paradigm - first patient dosed in USA under FDA approved EAP
Filed with ASX ·
6ix hasn’t read this filing yet.
Paradigm Biopharmaceuticals Ltd. on 6ix
Story so far
Earlier from Paradigm Biopharmaceuticals
- Paradigm presents MPS VI poster at WORLD Symposium
- Cleansing Notice and Appendix 3B
- Paradigm End of Calendar Year Update
- Paradigm AGM Presentation
- Paradigm provides regulatory filing update
Later from Paradigm Biopharmaceuticals
- Paradigm reports Positive Pre-IND meeting with US FDA
- All 10 participants in US FDA EAP have commenced treatment
- Voluntary Suspension
- Paradigm Latest Corporate Presentation
- Paradigm receives clarity on US regulatory pathway
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals